Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events

Neuroradiology

Volumn 46, Issue 2, 2004, Pages 113-117

  Abe, K ^a   Yoshimura, H ^a   Tanaka, H ^a   Fujita, N ^a   Hikita, T ^a   Sakoda, S ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diffusion weighted imaging; Magnetic resonance spectroscopy; Mitochondrial cytopathy; Stroke like episodes

Indexed keywords

ADULT; ARTICLE; ATAXIA; CEREBRAL BLINDNESS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HEARING IMPAIRMENT; HEMIPARESIS; HUMAN; IMAGING SYSTEM; INTERMETHOD COMPARISON; LACTIC ACIDOSIS; MALE; MELAS SYNDROME; MITOCHONDRIAL ENCEPHALOPATHY; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NYSTAGMUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; STROKE;

ADOLESCENT; ADULT; CEREBRAL CORTEX; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; DOMINANCE, CEREBRAL; FEMALE; FRONTAL LOBE; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LACTIC ACID; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MELAS SYNDROME; MIDDLE AGED; NEUROLOGIC EXAMINATION; OCCIPITAL LOBE; SENSITIVITY AND SPECIFICITY;

EID: 1642273787     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-003-1138-2     Document Type: Article

References (24)

1. Pavlakis SG, Phillips PC, DiMauro S, et al (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes: A distinctive clinical syndrome. Ann Neurol 16: 481-488
2. Ohama E, Ohara S, Ikuta F, et al (1987) Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 74: 226-233
3. Molnar MJ, Valikovics A, Molnar S, et al (2000) Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 55: 544-548
4. Castillo M, Kwock L, Green C (1995) MELAS syndrome: Imaging and proton MR spectroscopic findings. AJNR 16: 233-239
5. Barkovich AJ, Good WV, Koch TK, et al (1993) Mitochondrial disorders: Analysis of their clinical and imaging characteristics. AJNR 14: 1119-1137
6. Goto Y, Nonaka I, Horai S (1097) A new mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta 1097: 238-240
7. Kotsimbos N, Jean-Francois MJB, Huizing M, et al (1994) Rapid and non-invasive screening of patients with mitochondrial myopathy. Hum Mutat 4: 132-135
8. Abe K, Terakawa H, Takanashi M, et al (2000) Proton magnetic resonance spectroscopy of patients with parkinsonism. Brain Res Bull 52: 589-595
9. Oppenheim C, Galanaud D, Samson Y, et al (2000) Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 69: 248-250
10. Majoie CB, Akkerman EM, Blank C, et al (2002) Comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: Case report. AJNR 23: 813-816
11. Pavlakis SG, Kingsley PB, Kaplan GP, et al (1998) Magnetic resonance spectroscopy. Use in monitoring MELAS treatment. Arch Neurol 55: 849-852
12. Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, Kuriyama M (1999). Vasogenic edema in MELAS: A serial study with diffusion-weighted MR imaging. Neurology 53: 2182-2184
13. Kamada K, Takeuchi F, Houkin K, et al (2001) Reversible brain dysfunction in MELAS: MEG, and 1H MRS analysis. J Neurol Neurosurg Psychiatry 70: 675-678
14. Abe K, Inui T, Hirono N, Mezaki T, Kobayashi Y, Kameyama M (1990) Fluctuating MR images with mitochondrial encephalopathy, lactic acidosis, stroke-like syndrome (MELAS). Neuroradiology 32: 77
15. Clark JM, Marks MP, Adalsteinsson E, et al (1996) MELAS: clinical and pathologic correlations with MRI, Xenon/CT, and MR spectroscopy. Neurology 46: 223-227
16. Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S (1997) Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 49: 113-119
17. Le Bihan D, Breton E, Lallemand D, et al (1986) MR imaging of intravoxel incoherent motions: Application to diffusion and perfusion in neurologic disorders. Radiology 161: 401-407
18. Moseley ME, Cohen Y, Mintorovitch J, et al (1990) Early detection of regional cerebral ischemia in cats: Comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med 14: 330-346
19. Schaefer PW, Buonanno FS, Gonzalez RG, et al (1997) Diffusion weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 28: 1082-1085
20. Loubinoux I, Volk A, Borredon J, et al (1997) Spreading of vasogenic edema and cytotoxic edema assessed by quantitative diffusion and T2 magnetic resonance imaging. Stroke 28: 419-426
21. Kuroiwa T, Nagaoka T, Ueki M, et al (1998) Different apparent diffusion coefficient: Water content correlations of gray and white matter during early ischemia. Stroke 29: 859-865
22. Kucinski T, Vaterlein O, Glauche V, et al (2002) Correlation of apparent diffusion coefficient and computed tomography density in acute ischemic stroke. Stroke 33: 1786-1791
23. Fiehler J, Foth M, Kucinski T, et al (2002) Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 33: 79-86
24. Yoneda Y, Tokui K, Hanihara T, Kitagaki H, Tabuchi M, Mori E (1999) Diffusion-weighted magnetic resonance imaging: Detection of ischemic injury 33 minutes after onset in a stroke patient. Ann Neurol 45: 794-797